Skip to the page
Get started free

Data / Federal awards / NAICS 325412 / Department of Health and Human Services

Department of Health and Human Services contracts under NAICS 325412 Pharmaceutical Preparation Manufacturing: $19.4 billion to 164 recipients (FY2024 to FY2027)

Updated October 6, 2026. Source: USAspending.gov.

Department of Health and Human Services obligated $19.4 billion under NAICS 325412, Pharmaceutical Preparation Manufacturing, across 818 contract awards to 164 named recipients in fiscal years 2024 to 2027. The largest recipients are MERCK SHARP & DOHME LLC ($8.0 billion), PFIZER INC ($3.1 billion), SANOFI VACCINES US INC. ($2.7 billion). 13 opportunities under this code are open on SAM.gov now.

The request: Every federal contract awarded by Department of Health and Human Services under NAICS 325412, with the winner, the value and the period of performance. $10 of work on sign-up, no card.

Get contracts like theseWatch Department of Health and Human Services

SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.

Agency
Department of Health and Human Services
NAICS code
325412 Pharmaceutical Preparation Manufacturing
Contract awards
818
Obligated
$19.4 billion
Named recipients
164
Small business share of obligations
3%
Full and open competition share
92%
Set aside share
1%
Latest action
2026-09-30

Open opportunities in this niche

The same code on SAM.gov, read each morning: 13 opportunities you can still respond to.

Incumbents at this agency

Ranked by dollars obligated in fiscal years 2024 to 2027.

RecipientBusiness sizeAwardsObligatedShare
MERCK SHARP & DOHME LLCOther Than Small Business18$8.02 billion41.4%
PFIZER INCOther Than Small Business30$3.13 billion16.2%
SANOFI VACCINES US INC.Other Than Small Business33$2.74 billion14.2%
GLAXOSMITHKLINE, LLCOther Than Small Business25$2.58 billion13.3%
BAVARIAN NORDIC A/SOther Than Small Business1$463.4 million2.4%
MCKESSON CORPORATIONOther Than Small Business183$444.8 million2.3%
EMERGENT BIOSOLUTIONS CANADA INCOther Than Small Business2$355.5 million1.8%
ALVOGEN, INC.Other Than Small Business3$284.8 million1.5%
DLA TROOP SUPPORTOther Than Small Business3$253.5 million1.3%
PHLOW CORP.Small Business1$204.8 million1.1%
MODERNA US, INC.Other Than Small Business11$191 million1.0%
FRESENIUS KABI, LLCOther Than Small Business4$143.9 million0.7%
CHARTWELL RX LLCSmall Business4$142 million0.7%
GENENTECH USA, INCOther Than Small Business5$134.6 million0.7%
ELUSYS THERAPEUTICS INCOther Than Small Business3$124.3 million0.6%
SEQIRUS USA INCOther Than Small Business17$115.9 million0.6%
PARTNER THERAPEUTICS, INC.Small Business2$111.3 million0.6%
MERIDIAN MEDICAL TECHNOLOGIES, LLCOther Than Small Business3$82.6 million0.4%
EXELAN PHARMACEUTICALS INCOther Than Small Business1$74.1 million0.4%
RAFA LABORATORIES LTDOther Than Small Business1$33.4 million0.2%
ASTRAZENECA PHARMACEUTICALS LPOther Than Small Business17$31.6 million0.2%
USANTIBIOTICS LLCSmall Business1$30 million0.2%
BAXTER HEALTHCARE CORPORATIONOther Than Small Business16$28 million0.1%
INDIVIOR INC.Small Business1$22.8 million0.1%
SAGENT PHARMACEUTICALS, INCSmall Business2$16.6 million0.1%
HEYLTEX CORPORATIONSmall Business3$16.2 million0.1%
BAYER HEALTHCARE PHARMACEUTICALS INCOther Than Small Business2$15.1 million0.1%
BIOCRYST PHARMACEUTICALS INCSmall Business1$13.9 million0.1%
COHERUS ONCOLOGY, INC.Small Business1$11.8 million0.1%
WG CRITICAL CARE, LLCOther Than Small Business1$10.6 million0.1%
DYNAVAX TECHNOLOGIES CORPORATIONSmall Business4$8.3 million0.0%
ACCORD BIOPHARMA, INC.Small Business1$7.6 million0.0%
HIKMA PHARMACEUTICALS USA INC.Other Than Small Business1$7.5 million0.0%
SOUTHERNBELLE ROOM, LLCSmall Business1$6.2 million0.0%
BAVARIAN NORDIC, INC.Other Than Small Business6$6 million0.0%
FRESENIUS KABI USA, LLCOther Than Small Business1$5.4 million0.0%
WALGREEN CO.Other Than Small Business20$4.3 million0.0%
MRIGLOBALOther Than Small Business12$3.8 million0.0%
CURIA GLOBAL INCOther Than Small Business13$2.9 million0.0%
CARDINAL HEALTH 414, LLCOther Than Small Business40$2.3 million0.0%
ALCHEM LABORATORIES CORPORATIONSmall Business13$2.1 million0.0%
BTG INTERNATIONAL INCOther Than Small Business2$1.8 million0.0%
CENTRAL ADMIXTURE PHARMACY SERVICES, INCOther Than Small Business12$1.6 million0.0%
SERB MEDICAL SOLUTIONS INC.Small Business2$1.2 million0.0%
PROGENICS PHARMACEUTICALS INCSmall Business6$1.2 million0.0%
PINE PHARMACEUTICALS LLCSmall Business15$900,3150.0%
WE PHARMA, INC.Small Business8$799,6200.0%
SOCIETAL CDMO SAN DIEGO, LLCSmall Business15$784,1560.0%
VALNEVA USA, INC.Small Business7$665,1120.0%
CHARTWELL GOVERNMENTAL & SPECIALTY RX LLCSmall Business1$586,4380.0%

Offices buying

Sub agencyAwardsObligated
Centers for Disease Control and Prevention138$16.06 billion
Office of Assistant Secretary for Preparedness and Response102$2.57 billion
Indian Health Service273$468.1 million
National Institutes of Health267$274.8 million
Office of the Assistant Secretary for Administration22$3.2 million
Office of the Assistant Secretary for Financial Resources4$1.5 million
Food and Drug Administration12$968,171

Obligations by fiscal year

Fiscal yearObligated
FY2024$6.76 billion
FY2025$6.66 billion
FY2026$5.96 billion

Products and services bought

CodeProduct or serviceAwardsObligated
6505Drugs and Biologicals520$19.35 billion
AN17R&d- Medical: Biomedical (commercialized)1$204.8 million
3650Chemical and Pharmaceutical Products Manufacturing Machinery59$156.3 million
6515Medical and Surgical Instruments, Equipment, and Supplies53$141.7 million
Q999Medical- Other4$20.7 million
AN11Health R&d Services; Health Care Services; Basic Research19$20.7 million
AN13Health R&d Services; Health Care Services; Experimental Development12$4.5 million
Q517Pharmacy Services6$3.9 million

Largest contract awards

Award IDRecipientAgencyTypeNAICSWhat it buysObligated in windowAward valueStartsEndsPlace of performanceSource
75D30124D18656MERCK SHARP & DOHME LLCDepartment of Health and Human ServicesIDC3254122024-2025 VACCINES FOR CHILDREN$2,611,180,789$4,079,096,100April 1, 2024usaspending.gov
75D30125D00195MERCK SHARP & DOHME LLCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN FY25$2,407,704,840$4,382,496,700April 1, 2025usaspending.gov
75D30126D20729MERCK SHARP & DOHME LLCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN$1,762,731,059$4,481,646,300April 1, 2026usaspending.gov
75D30124D18657PFIZER INCDepartment of Health and Human ServicesIDC3254122024-2025 VACCINES FOR CHILDREN$1,128,929,283$1,914,795,500April 1, 2024usaspending.gov
75D30125D00194PFIZER INCDepartment of Health and Human ServicesIDC325412END OF PWS$1,123,734,612$2,007,801,001April 1, 2025usaspending.gov
75D30123D16108MERCK SHARP & DOHME LLCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN$1,037,852,652$3,942,689,200April 1, 2023usaspending.gov
75D30124D18658SANOFI VACCINES US INC.Department of Health and Human ServicesIDC3254122024-2025 VACCINES FOR CHILDREN$1,002,127,309$1,793,186,600April 1, 2024usaspending.gov
75D30125D00196SANOFI VACCINES US INC.Department of Health and Human ServicesIDC325412VACCINES FOR CHILDREN FY25$964,721,458$2,196,049,020April 1, 2025usaspending.gov
75D30124D18655GLAXOSMITHKLINE, LLCDepartment of Health and Human ServicesIDC3254122024-2025 VACCINES FOR CHILDREN$835,589,523$1,334,738,300April 1, 2024usaspending.gov
75D30125D00198GLAXOSMITHKLINE, LLCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN FY25$793,016,570$928,389,595April 1, 2025usaspending.gov
75D30126D20728GLAXOSMITHKLINE, LLCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN$677,820,295$1,465,091,900April 1, 2026usaspending.gov
75D30126D20730PFIZER INCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN$661,393,280$2,091,499,500April 1, 2026usaspending.gov
75D30126D20731SANOFI VACCINES US INC.Department of Health and Human ServicesIDC325412VACCINES FOR CHILDREN$579,568,176$1,882,007,500April 1, 2026usaspending.gov
HHSO100201700019CBAVARIAN NORDIC A/SDepartment of Health and Human ServicesDefinitive Contract325412IGF::OT::IGF$463,447,837$1,264,240,981September 27, 2017September 26, 2027Denmarkusaspending.gov
75D30123D16109PFIZER INCDepartment of Health and Human ServicesIDC325412VACCINES FOR CHILDREN$417,577,797$1,528,101,076April 1, 2023usaspending.gov
75A50325F80013ALVOGEN, INC.Department of Health and Human ServicesDelivery Order325412OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); $227,679,090$227,679,090June 30, 2025June 29, 2027Pine Brook, NJusaspending.gov
75A50120C00092PHLOW CORP.Department of Health and Human ServicesDefinitive Contract325412US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THRE$204,760,551$708,849,576May 18, 2020January 13, 2027Richmond, VAusaspending.gov
75A50119C00075EMERGENT BIOSOLUTIONS CANADA INCDepartment of Health and Human ServicesDefinitive Contract325412BOTULISM ANTITOXIN$187,180,193$320,923,453September 30, 2019March 30, 2027Canadausaspending.gov
75A50119C00037EMERGENT BIOSOLUTIONS CANADA INCDepartment of Health and Human ServicesDefinitive Contract325412VIGIV BUY AND ASSOCIATED SERVICES$168,348,063$422,315,784May 31, 2019March 30, 2027Canadausaspending.gov
75A50124C00057MERCK SHARP & DOHME LLCDepartment of Health and Human ServicesDefinitive Contract325412ERVEBO PROCUREMENT$156,033,983$156,033,983September 30, 2024September 29, 2034Rahway, NJusaspending.gov
75D30123C17978MCKESSON SPECIALTY DISTRIBUTION LLCDepartment of Health and Human ServicesDefinitive Contract325412CENTRALIZED VACCINE DISTRIBUTION$146,295,445$326,075,034February 1, 2024January 31, 2027Memphis, TNusaspending.gov
75A50325F80009CHARTWELL RX LLCDepartment of Health and Human ServicesDelivery Order325412DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS$144,579,702$144,579,702June 23, 2025June 22, 2027Congers, NYusaspending.gov
75A50324C00006ELUSYS THERAPEUTICS INCDepartment of Health and Human ServicesDefinitive Contract325412ANTHIM (OBILTOXAXIMAB)$124,523,123$124,523,123May 1, 2024December 31, 2028Parsippany, NJusaspending.gov
75D30125D20470MODERNA US, INC.Department of Health and Human ServicesIDC325412PEDIATRIC COVID VACCINES$120,364,534$196,917,000June 1, 2025usaspending.gov
75A50325C00004FRESENIUS KABI, LLCDepartment of Health and Human ServicesDefinitive Contract325412BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER$111,677,559$111,677,559March 14, 2025March 13, 2030Lake Zurich, ILusaspending.gov

Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.